Retatrutide 30MG
$300.00
Lyophilized powder, 30mg per vial
Retatrutide is a novel GLP-1/GIP/glucagon triple receptor agonist studied in preclinical research contexts. This 30mg format supports extended laboratory protocols investigating multi-pathway metabolic signaling, receptor interactions, glucose homeostasis, and energy metabolism mechanisms. The compound is supplied as a research-grade lyophilized powder and is intended exclusively for controlled laboratory research by qualified researchers.
Research Applications
- ✓30mg format for extended research protocols
- ✓Triple receptor agonist research
- ✓Studied in metabolic signaling investigations
- ✓Research-grade lyophilized compound
Coming Soon
This product is not available to purchase yet.
Research Use Only: This product is for laboratory research only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Product Information
Retatrutide is a novel GLP-1/GIP/glucagon triple receptor agonist studied in preclinical research contexts. This 30mg format supports extended laboratory protocols investigating multi-pathway metabolic signaling, receptor interactions, glucose homeostasis, and energy metabolism mechanisms. The compound is supplied as a research-grade lyophilized powder and is intended exclusively for controlled laboratory research by qualified researchers.
Commonly Studied In:
- •30mg format for extended research protocols
- •Triple receptor agonist research
- •Studied in metabolic signaling investigations
- •Research-grade lyophilized compound
